Results 31 to 40 of about 358,718 (162)

Dose‐Dependent Efficacy of Radioiodine Therapy in Pediatric Graves’ Disease: A Retrospective Study of Hypothyroidism Risk and the Predictive Role of Thyroid Hormone Parameters

open access: yesiRADIOLOGY, Volume 4, Issue 5, Page 385-392, October 2026.
RAI therapy demonstrated time‐dependent efficacy in pediatric Graves' disease, with gradually increasing treatment success and hypothyroidism incidence during follow‐up. Higher planned activity (≥ 0.15 mCi/g) was associated with a higher successful rate than lower planned activity (< 0.15 mCi/g), and LASSO analysis identified FT3 and TSH as candidate ...
Xiaoxue Tian   +8 more
wiley   +1 more source

Autoimmunity: Molecular Mechanisms, Biomarkers, and Therapeutic Opportunities

open access: yesMedComm, Volume 7, Issue 9, September 2026.
Major types of immunometabolism, epigenetics, posttranscriptional regulation, and functional reprogramming involved in autoimmune diseases. The roles of immunometabolism, epigenetics, posttranscriptional regulation, and functional reprogramming in autoimmune diseases have been a major research focus in recent years.
Jialong Kuang   +10 more
wiley   +1 more source

COVID-19: a new etiological factor of Graves’ disease?

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2020
SARS-CoV-2 rapidly became a pandemic and has affected millions of people worldwide. Even though the main target of the coronavirus is the respiratory system, researchers all over the world are increasingly concerned about the problem of the impact of ...
A.M. Urbanovych   +3 more
doaj   +1 more source

Hormones and dry eye disease

open access: yesIndian Journal of Ophthalmology, 2023
The endocrine system influences all tissues and cells in the human body. The ocular surface is constantly exposed to circulating hormones and expresses their specific receptors.
Bhavya Gorimanipalli   +3 more
doaj   +1 more source

Trends of Eye and Adnexa‐Related Hospital Admissions in Lebanon: An Epidemiological Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aim Visual impairment represents a major public health concern, affecting millions of individuals worldwide. In recent years, the global burden of eye diseases and vision impairment has continued to grow. This study aims to investigate the trends in eye and adnexa‐related hospital admissions in Lebanon from 2006 to 2019, as ...
Dany Akiki   +5 more
wiley   +1 more source

MINIMALLY INVASIVE METHODS OF SURGICAL TREATMENT OF ENDOCRINE OPHTHALMOPATHY

open access: yesOftalʹmologiâ, 2017
“Balanced” bone  decompression of the  orbit was  performed in a patient  with endocrine ophthalmopathy, CAS3, OD=30 mm,  OS=31 mm with the use of minimally invasive transconjunctival approaches and frameless neuronavigation.
O. V. Levchenko   +4 more
doaj   +1 more source

Retinal Capillary Density Reduction Contributes to Dysthyroid Optic Neuropathy via an L‐Arginine‐NO Pathway: A Metabonomics and Clinical Trial Study

open access: yesMedComm, Volume 7, Issue 3, March 2026.
Oxidative stress induces endothelial nitric oxide synthase (eNOS) uncoupling and L‐arginine depletion, reducing nitric oxide (NO) bioavailability in vascular endothelium and contributing to decreased retinal capillary density (RCD) in dysthyroid optic neuropathy (DON).
Yunhai Tu   +12 more
wiley   +1 more source

The Diagnostic Value of Mean Apparent Propagator‐MRI in Dysthyroid Optic Neuropathy: A Quantitative Analysis of the Entire Visual Pathway

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 2, February 2026.
The diagnostic model combining orbital and intracranial MAP‐MRI parameters could significantly optimize diagnostic efficiency of dysthyroid optic neuropathy. Comprehensive MAP‐MRI parameters analysis of the entire visual pathway enables a deeper understanding of disease involvement, provides novel insights into the early accurate diagnosis and ...
Mengsha Zou   +7 more
wiley   +1 more source

Teprotumumab for Thyroid Eye Disease: Efficacy and Impact on Orbital Decompression Utilization

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 1, February 2026.
Teprotumumab has been proven effective in thyroid eye disease and associated exophthalmos management. Since its FDA approval in 2020, teprotumumab therapy has been a popular choice for managing exophthalmos which has resulted in decreased utilization of orbital decompression surgery, from 36.8% between 2015 and 2020 to 11.1% TED patients between 2020 ...
Nitish Kumar   +5 more
wiley   +1 more source

Morphofunctional characteristics and immunological regulation of the orbital fibroblasts function in endocrine ophthalmopathy

open access: yesКлиническая и экспериментальная тиреоидология, 2019
Endocrine ophthalmopathy (EOP) is a chronic disease characterized by progressive autoimmune inflammation of the soft retrobulbar tissues in thyroid dysfunction.
Elizaveta S. Taskina   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy